在地平线上有希望:对稳定性肝病有前途的治疗方法

Amirhossein Sahebkar1, Ali H Eid2

  • 1Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India (A.S.); Biotechnology Research Center, Pharmaceutical Technology Institute (A.S.) and Applied Biomedical Research Center (A.S.), Mashhad University of Medical Sciences, Mashhad, Iran; and Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar (A.H.E.) ali.eid@qu.edu.qa.

PubMed
概括

脂肪性肝病 (SLD) 构成了全球重大健康挑战. 了解SLD病理生理学的进步,诊断,以及像resmetirom这样的新疗法,为改善患者结果提供了希望.